News headlines about Orthopediatrics (NASDAQ:KIDS) have been trending somewhat positive on Sunday, Accern reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Orthopediatrics earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 46.5249129292565 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Orthopediatrics stock traded up $0.16 during trading on Friday, hitting $15.06. The company had a trading volume of 52,273 shares, compared to its average volume of 56,034. Orthopediatrics has a 1-year low of $14.47 and a 1-year high of $23.00. The company has a debt-to-equity ratio of 0.53, a quick ratio of 5.29 and a current ratio of 7.35. The company has a market capitalization of $192.33 and a PE ratio of -2.64.
A number of analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Wednesday, March 14th. BidaskClub downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Finally, BTIG Research restated a “buy” rating and set a $24.00 price target on shares of Orthopediatrics in a report on Friday, January 5th. Two analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. Orthopediatrics currently has an average rating of “Hold” and a consensus price target of $23.67.
COPYRIGHT VIOLATION NOTICE: This story was reported by WKRB News and is owned by of WKRB News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.wkrb13.com/2018/04/01/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-orthopediatrics-kids-share-price.html.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.